INTUITIVE SURGICAL INC (1ISRG.MI) Fundamental Analysis & Valuation

BIT:1ISRG • US46120E6023

Current stock price

408.8 EUR
-10.6 (-2.53%)
Last:

This 1ISRG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1ISRG.MI Profitability Analysis

1.1 Basic Checks

  • 1ISRG had positive earnings in the past year.
  • 1ISRG had a positive operating cash flow in the past year.
  • 1ISRG had positive earnings in each of the past 5 years.
  • 1ISRG had a positive operating cash flow in each of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.96%, 1ISRG belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
  • 1ISRG has a Return On Equity of 16.02%. This is amongst the best in the industry. 1ISRG outperforms 88.71% of its industry peers.
  • 1ISRG's Return On Invested Capital of 13.95% is amongst the best of the industry. 1ISRG outperforms 91.94% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is above the industry average of 10.01%.
  • The 3 year average ROIC (12.43%) for 1ISRG is below the current ROIC(13.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 28.38%, 1ISRG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1ISRG has grown nicely.
  • 1ISRG's Operating Margin of 29.35% is amongst the best of the industry. 1ISRG outperforms 98.39% of its industry peers.
  • In the last couple of years the Operating Margin of 1ISRG has grown nicely.
  • With a decent Gross Margin value of 66.00%, 1ISRG is doing good in the industry, outperforming 74.19% of the companies in the same industry.
  • 1ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 1ISRG.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
  • The number of shares outstanding for 1ISRG has been reduced compared to 1 year ago.
  • 1ISRG has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 39.99 indicates that 1ISRG is not in any danger for bankruptcy at the moment.
  • 1ISRG has a Altman-Z score of 39.99. This is amongst the best in the industry. 1ISRG outperforms 98.39% of its industry peers.
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 39.99
ROIC/WACC1.3
WACC10.7%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • 1ISRG has a Current Ratio of 4.87. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • 1ISRG has a better Current ratio (4.87) than 96.77% of its industry peers.
  • 1ISRG has a Quick Ratio of 3.96. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • 1ISRG's Quick ratio of 3.96 is amongst the best of the industry. 1ISRG outperforms 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1ISRG.MI Growth Analysis

3.1 Past

  • 1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • Looking at the last year, 1ISRG shows a very strong growth in Revenue. The Revenue has grown by 20.51%.
  • The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.58% yearly.
  • 1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.90% yearly.
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue Next Year15.88%
Revenue Next 2Y14.86%
Revenue Next 3Y14.57%
Revenue Next 5Y12.9%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1ISRG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 52.75, 1ISRG can be considered very expensive at the moment.
  • 61.29% of the companies in the same industry are cheaper than 1ISRG, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 24.88. 1ISRG is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 46.06 indicates a quite expensive valuation of 1ISRG.
  • 1ISRG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 66.13% of the companies in the same industry.
  • 1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 52.75
Fwd PE 46.06
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 64.52% of the companies are valued more cheaply.
  • 1ISRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 67.14
EV/EBITDA 43.66
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1ISRG may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.52% in the coming years.
PEG (NY)3.65
PEG (5Y)2.46
EPS Next 2Y14.34%
EPS Next 3Y14.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ISRG.MI Dividend Analysis

5.1 Amount

  • No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ISRG.MI Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

BIT:1ISRG (3/25/2026, 7:00:00 PM)

408.8

-10.6 (-2.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-21
Inst Owners88.53%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap145.19B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target539.67 (32.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)1.07%
PT rev (3m)3.53%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)0%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.01%
Valuation
Industry RankSector Rank
PE 52.75
Fwd PE 46.06
P/S 16.61
P/FCF 67.14
P/OCF 55.18
P/B 9.38
P/tB 9.59
EV/EBITDA 43.66
EPS(TTM)7.75
EY1.9%
EPS(NY)8.87
Fwd EY2.17%
FCF(TTM)6.09
FCFY1.49%
OCF(TTM)7.41
OCFY1.81%
SpS24.61
BVpS43.57
TBVpS42.63
PEG (NY)3.65
PEG (5Y)2.46
Graham Number87.17
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 39.99
F-Score8
WACC10.7%
ROIC/WACC1.3
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.88%
Revenue Next 2Y14.86%
Revenue Next 3Y14.57%
Revenue Next 5Y12.9%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.56%
EBIT Next 3Y21.57%
EBIT Next 5Y17.26%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for 1ISRG stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 52.75 and the Price/Book (PB) ratio is 9.38.


Can you provide the financial health for 1ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 9 / 10.